| PICO 6: treatment: pegylated interferon plus ribavirin versus standard interferon plus ribavirin for chronic hepatitis C infection: a meta-analytical systematic review World Health Organization World Health Organization, 2014 | 5184* | 2014 |
| Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission GS Cooke, I Andrieux-Meyer, TL Applegate, R Atun, JR Burry, ... The Lancet Gastroenterology & Hepatology 4 (2), 135-184, 2019 | 502* | 2019 |
| The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma DJ Pinato, R Sharma, E Allara, C Yen, T Arizumi, K Kubota, D Bettinger, ... Journal of hepatology 66 (2), 338-346, 2017 | 346 | 2017 |
| Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study M Lemoine, Y Shimakawa, R Njie, M Taal, G Ndow, I Chemin, S Ghosh, ... The Lancet Global Health 4 (8), e559-e567, 2016 | 161 | 2016 |
| Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade N Scott, JS Doyle, DP Wilson, A Wade, J Howell, A Pedrana, A Thompson, ... International Journal of Drug Policy 47, 107-116, 2017 | 143 | 2017 |
| Outcomes of treatment for hepatitis C in prisoners using a nurse-led, statewide model of care T Papaluca, L McDonald, A Craigie, A Gibson, P Desmond, D Wong, ... Journal of hepatology 70 (5), 839-846, 2019 | 104 | 2019 |
| Prevention of materno‐foetal transmission of hepatitis B in sub‐Saharan Africa: the evidence, current practice and future challenges J Howell, M Lemoine, M Thursz Journal of viral hepatitis 21 (6), 381-396, 2014 | 73 | 2014 |
| T oll‐like receptors in hepatitis C infection: Implications for pathogenesis and treatment J Howell, P Angus, P Gow, K Visvanathan Journal of gastroenterology and hepatology 28 (5), 766-776, 2013 | 69 | 2013 |
| The emerging burden of liver disease in cystic fibrosis patients: A UK nationwide study MB Toledano, SK Mukherjee, J Howell, D Westaby, SA Khan, D Bilton, ... PloS one 14 (4), e0212779, 2019 | 66 | 2019 |
| A global investment framework for the elimination of hepatitis B J Howell, A Pedrana, SE Schroeder, N Scott, L Aufegger, R Atun, ... Journal of hepatology 74 (3), 535-549, 2021 | 62 | 2021 |
| Cyclosporine and tacrolimus have inhibitory effects on toll‐like receptor signaling after liver transplantation J Howell, R Sawhney, A Testro, N Skinner, P Gow, P Angus, D Ratnam, ... Liver Transplantation 19 (10), 1099-1107, 2013 | 61 | 2013 |
| Innovative strategies for the elimination of viral hepatitis at a national level: A country case series SE Schröeder, A Pedrana, N Scott, D Wilson, C Kuschel, L Aufegger, ... Liver International 39 (10), 1818-1836, 2019 | 59 | 2019 |
| Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma J Howell, SR Atkinson, DJ Pinato, S Knapp, C Ward, R Minisini, ... European Journal of Cancer 116, 56-66, 2019 | 59 | 2019 |
| Aiming for the elimination of viral hepatitis in Australia, New Zealand, and the Pacific Islands and Territories: Where are we now and barriers to meeting World Health … J Howell, A Pedrana, BC Cowie, J Doyle, A Getahun, J Ward, E Gane, ... Journal of gastroenterology and hepatology 34 (1), 40-48, 2019 | 56 | 2019 |
| Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility study B Williams, J Howell, J Doyle, AJ Thompson, B Draper, C Layton, ... International Journal of Drug Policy 72, 91-98, 2019 | 51 | 2019 |
| On‐target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi‐centre, prospective study J Howell, DJ Pinato, R Ramaswami, D Bettinger, T Arizumi, C Ferrari, ... Alimentary pharmacology & therapeutics 45 (8), 1146-1155, 2017 | 51 | 2017 |
| HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta‐analysis I Lockart, MGH Yeo, B Hajarizadeh, GJ Dore, M Danta, K Abe, F Carrat, ... Hepatology 76 (1), 139-154, 2022 | 47 | 2022 |
| Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib JA Howell, DJ Pinato, R Ramaswami, T Arizumi, C Ferrari, A Gibbin, ... Oncotarget 8 (22), 36161, 2017 | 41 | 2017 |
| Early‐onset versus late‐onset nonanastomotic biliary strictures post liver transplantation: risk factors reflect different pathogenesis JA Howell, PJ Gow, PW Angus, RM Jones, BZ Wang, M Bailey, MA Fink Transplant International 25 (7), 765-775, 2012 | 41 | 2012 |
| delivering precision oncology in intermediate‐stage liver cancer DJ Pinato, J Howell, R Ramaswami, R Sharma Alimentary pharmacology & therapeutics 45 (12), 1514-1523, 2017 | 40 | 2017 |
